Verification of the Utility of Urinary L-FABP as a Predictor of Impaired Renal Function Based on Its Relationship with Changes in Renal Function
Journal of Clinical Medicine · 16.03.2026 · 15 (6) · 2243
DOI: 10.3390/jcm15062243 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 16.03.2026. Verfasst von Yuichi Kato und 1 weiteren Autor:innen. Beteiligte Einrichtung: National Hospital Organization Kumamoto Saishun Medical Center, 2659 Suya, Koshi 861-1196, Kumamoto, Japan. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
In patients with diabetes or hypertension, if appropriate intervention is not initiated early in the course of kidney disease, not only does the risk of progressing to end-stage renal failure increase, but mortality associated with vascular complications also rises as the disease progresses; therefore, there is an urgent need to develop urinary biomarkers that enable early diagnosis and prediction of disease progression.
Methods
This two-year prospective observational study involved 185 outpatients. Patients were classified into two groups based on their baseline urinary L-FABP levels relative to the reference value of 8.4 μg/g·Cr at the start of the study. The rate of eGFR decline during the observation period was evaluated.
Results
The results showed an interaction (synergistic effect) between urinary L-FABP and time in patients with diabetes or hypertension who had an eGFR of at least 60 mL/min/1.732 m2/kg/1.732 m2. Patients with high urinary L-FABP levels (>8.4 μg/g·Cr) exhibited a notably faster eGFR decline compared with those with low levels (≤8.4 μg/g·Cr). This finding suggests the potential of urinary L-FABP as a predictor of renal function decline; we evaluated this utility using the area under the ROC curve (AUC) and logistic regression analysis. The results indicate that urinary L-FABP holds potential as a predictor of renal function decline in diabetic or hypertensive patients with preserved eGFR.
Conclusions
Among the analysis groups in which the validation was conducted, it was demonstrated that urinary L-FABP holds potential as a predictor of renal function decline in patients with diabetes or hypertension who have a maintained eGFR. Given that urinary L-FABP is thought to reflect tubulointerstitial damage associated with renal microcirculatory impairment, its future utility as a urinary biomarker for the early diagnosis and prognosis of chronic kidney disease (CKD) is anticipated.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Hospital Organization Kumamoto Saishun Medical Center, 2659 Suya, Koshi 861-1196, Kumamoto, Japan.
- Department of Nephrology and Hypertension, St. Marianna University School of Medicine, 2-16-1 Sugao, Miyamae Ward, Kawasaki 216-0015, Kanagawa, Japan.
ORCID-Profile: Takeshi Sugaya
Zitieren
APA
Kato, Y., & Sugaya, T. (2026). Verification of the Utility of Urinary L-FABP as a Predictor of Impaired Renal Function Based on Its Relationship with Changes in Renal Function. Journal of Clinical Medicine, 15(6), 2243. https://doi.org/10.3390/jcm15062243
Vancouver
Kato Y, Sugaya T. Verification of the Utility of Urinary L-FABP as a Predictor of Impaired Renal Function Based on Its Relationship with Changes in Renal Function. Journal of Clinical Medicine. 2026;15(6):2243. doi:10.3390/jcm15062243
BibTeX
@article{Kato2026,
author = {Kato, Yuichi and Sugaya, Takeshi},
title = {Verification of the Utility of Urinary L-FABP as a Predictor of Impaired Renal Function Based on Its Relationship with Changes in Renal Function},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {6},
pages = {2243},
doi = {10.3390/jcm15062243}
}
EUVIMED